ASSAY and Drug Development Technologies

Published in Association with Mary Ann Liebert

Other Titles in:
Assay Development/Screening | Biotechnology | Pharmaceutical Science

eISSN: 15578127 | ISSN: 1540658X | Current volume: 23 | Current issue: 7 Frequency: Not Yet Specified

Download flyer Recommend to Library

Preview this book

This journal provides access to novel techniques and robust tools that enable critical advances in early-stage screening. The research published in this journal leads to important therapeutics and platforms for drug discovery and development. As a reputable peer-reviewed journal, it features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.

ASSAY and Drug Development Technologies coverage includes:
Assay design, target development, and high-throughput technologies
Hit to Lead optimization and medicinal chemistry through preclinical candidate selection
Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis
Approaches to assays configured for gene families, inherited, and infectious diseases
Assays and strategies for adapting model organisms to drug discovery
The use of stem cells as models of disease
Translation of phenotypic outputs to target identification
Exploration and mechanistic studies of the technical basis for assay and screening artifacts
The Journal also features a dedicated Drug Repurposing, Rescue, and Repositioning (DRRR) section. These special peer-reviewed collections of papers present techniques and tools for finding new uses for approved drugs – particularly for disorders where no animal model, physiologic abnormality, biochemical pathway, or molecular target has been identified.

This DRRR special section features original papers, application-oriented technology reviews, and reports in methodology and technology application to drug repurposing and redevelopment including:

Designing assays and interpreting output to enable alternate drug target identification
Pathway analysis and bioinformatics to identify and exploit drug promiscuity
In silico technologies to identify alternate drug targets
"Big Data" mining and side effect pattern analysis in clinical and healthcare repositories
ASSAY and Drug Development Technologies is under the editorial leadership of Editor-in-Chief Wai Hong (Kevin) Lo, PhD, Vanderbilt University School of Medicine; and other leading investigators.The DRRR section is under the leadership of Hermann Mucke, PhD, of H. M. Pharma Consultancy.

Journal Audience Includes: Drug discovery and assay development scientists, drug delivery and formulation specialists, molecular and behavioral pharmacologists, pharmaceutical and biotechnology researchers, and disease foundation advocates, among others.

Editor-in-Chief

Wai Hong Lo, PhD

University of Connecticut Health Center, Farmington, CT, USA

Associate Editors

Michelle Arkin, PhD	Univ Of California San Francisco, San Francisco, CA, USA
Haian Fu, PhD	Emory University School of Medicine, Atlanta, GA, USA
Thomas Lundbäck, PhD	AstraZeneca, Gothenburg, Sweden

Literature Editors

Doug Auld, PhD	Novartis Institutes for BioMedical Research, Cambridge, MA, USA
Anton Simeonov, PhD	National Institutes of Health, Bethesda, MD, USA

Editorial Board

Guleid Awale, PhD	Pfizer, Groton, CT, USA
Mohammed A. Barajaa, PhD	Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
Stephen J Benkovic	Pennsylvania State University, University Park, PA, USA
Laura Berliocchi, PhD	Magna Graecia University, Catanzaro, Italy
Maumita Bhattacharjee, PhD	Celularity Inc, Florham Park, NJ, USA
Leo S. Bleicher, AB	Cepheus Information Systems, San Diego, CA, USA
Bruce E. Bloom, JD, DDS	Healx Ltd., Deerfield, IL, USA
Diane J. Burgess, PhD	University of Connecticut, Storrs, CT, USA
Susan Catalano, PhD	Cognition Therapeutics Inc, Pittsburgh, PA, USA
Francesco S Celi, MD, MHSC	University of Connecticut Health Center, Farmington, CT, USA
Hugh Hiu Nam Chan, PhD	Cleveland Clinic, Cleveland, OH, USA
Harsh Chauhan, PhD	Creighton University, Omaha, NE, USA
Daniel Chelsky, PhD	Caprion Pharmaceuticals, Montreal, Quebec, Canada
Namjin Chung, PhD	Bristol-Myers Squibb Co., Hopewell, NJ, USA
Hakim Djaballah, PhD	Keren Therapeutics, Scarsdale, NY, USA
Stephen C. Ekker, PhD	University of Texas at Austin, Austin, TX, USA
Darryl Falzarano, PhD	University of Saskatchewan, Saskatoon, SK, Canada
Frank Fan, PhD	Promega Corporation, Madison, WI, USA
Thomas L. Fare, PhD	Merck & Co., Inc., Lansdale, PA, USA
Dan Fitzpatrick, PhD	Amgen, Inc., Thousand Oaks, CA, USA
Georgios V. Gkoutos, BSc, MSc, PhD, DIC	University of Aberystwyth, Dyfed, United Kingdom
J. Fraser Glickman, MPH, PhD	Rockefeller University, New York, NY, USA
Samuel Hasson, PhD	Amgen Neuroscience, Cambridge, MA, USA
Christopher Heise, PhD	Genentech Inc, South San Francisco, CA, USA
Ilkka Hemmilä, PhD	PerkinElmer Life Sciences, Turku, Finland
Paul A Johnston, PhD	University Of Pittsburgh School Medicine, Pittsburgh, PA, USA
Robert J. Lefkowitz, MD	HHMI/Duke University Medical Center, Durham, NC, USA
Jay Liu, PhD	Rugen Therapeutics, Shanghai, China
Ralph R Martel	High Throughput Genomics Inc, Tucson, AZ, USA
Lorenz Mayr, PhD	Novartis Pharma AG / NIBR, Basel, Switzerland
Patricia McDonald, PhD	The Scripps Research Institute, Jupiter, FL, USA
Xiulei Mo, PhD	Emory University, Atlanta, GA, USA
Walter D Niles, PhD	Aurora Biotechnologies Inc, La Jolla, CA, USA
Kevin R. Oldenburg, PhD	Matrical, Spokane, WA, USA
Hiroyuki Osada, PhD	RIKEN Center for Sustainable Resource Science, Saitama, Japan
Takayoshi Otsuka, PhD	Niigata University, Niigata, Japan
Young-Whan Park, PhD	National Oncoventure At National Cancer Center, Gyeonggi-Do, South Korea
Jeffrey H Price, MD, PhD	Burnham Institute For Medical Research, La Jolla, CA, USA
John R. Raymond, MD	Medical College of Wisconsin, Milwaukee, WI, USA
E. Mitchell Seymour, PhD, RAC	Michigan Institute for Clinical and Health Research, Ann Arbor, MI, USA
Kaylene J. Simpson, PhD	Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Gary Skinner, PhD	Illumina United Kingdom, Essex, United Kingdom
Sharon F. Terry, MA	Genetic Alliance Washington, DC, USA
Jeffrey H. Toney, PhD	Kean University, Union, NJ, USA
Bret Ulery, PhD	University of Missouri, Columbia, MO, USA
Richard B. van Breemen, PhD	University of Illinois College of Pharmacy, Chicago, IL, USA
Henry VanBrocklin, PhD	University of California, San Francisco, USA
Christian R Voolstra, PhD	University of Konstanz, Konstanz, Germany
Joseph Walker, MD	University of Connecticut, Farmington, CT, USA
Jun Wang, PhD	Lynk Pharmaceuticals, Zhejiang, China
Charles D. Weaver, PhD	Vanderbilt Medical School, Nashville, TN, USA
Holly Yin, PhD	City Of Hope National Medical Center, Duarte, CA, USA
Guido JR Zaman, PhD	Netherlands Translational Research Center B.V. Oss, Netherlands
Zhong Zhong, PhD	Generation Bio, Cambridge, MA, USA

Founding Editor

Jim Inglese, PhD

Bethesda, MD, USA

Editor Emeritus

Bruce J. Melancon, PhD

Nashville, TN, USA

BIOSIS database

Chemical Abstracts

Clarivate Analytics: Biological Abstracts

EBSCO

EMBASE/Excerpta Medica

Journal Citation Reports/Science Edition

MEDLINE/PubMed (NLM)

ProQuest

PsychINFO

PubMed: PubMed Central (PMC)

Scopus

Web of Science: Science Citation Index Expanded (SCIE)

You are here

Preview this book